Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -1.30 (-1.24%)
Bid:
102.70
Ask:
103.40
Spread: 0.70 (0.682%)
Market Cap: £383.04m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Directorate Change

5 Jul 2022 07:00

RNS Number : 2862R
RWS Holdings PLC
05 July 2022
 

RNS - Appointment of Chief Financial Officer

 

 

For immediate release 5 July 2022

 

RWS Holdings plc

 

Board Change

Appointment of Chief Financial Officer

 

 

RWS Holdings plc ("RWS" or "the Group"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces the appointment of Candida (Candy) Davies as Chief Financial Officer with effect from 1 October 2022. She will join the Board and the Group Executive Team.

 

Candy was most recently Head of Finance for the Personal Health division of Royal Philips, the Dutch-headquartered health technology conglomerate, where she also supported the Group Innovation and Strategy function. She has considerable experience in commercial and operational leadership and played a key role in driving market innovation, new business models and solutions to support enhancing patient and consumer experience, improving health outcomes, and driving sustainable performance. Prior to this she spent eight years at Reckitt Benckiser, latterly as European Finance Director for the Hygiene and Home Business Unit, having previously been Senior Vice President and Corporate Controller for the group. Earlier in her career, she spent twelve years with Eli Lilly & Co, having gained chartered accountant status at KPMG.

 

Ian El-Mokadem, Chief Executive Officer, commented:

 

"I am delighted that we have appointed Candy as Chief Financial Officer. Her international, blue-chip and health sector experience combined with her expertise across finance, strategy and innovation will be invaluable to the Board and the Executive team, as we continue to focus on delivering our accelerated growth plan."

 

Candy Davies, Chief Financial Officer designate, commented:

 

"I look forward to joining RWS and working with its leadership team to build on its strong client relationships, ability to offer a unique blend of services and technology at scale, and leading position in large, attractive, growing markets, to deliver on its medium-term growth strategy." 

 

Rod Day will continue as Interim CFO and complete a thorough handover before leaving RWS by the end of 2022.

 

Other than the previous directorships set out at the end of this announcement, there is no further information required to be disclosed pursuant to paragraph (g) of Schedule Two of the AIM Rules for Companies, in relation to Candy Davies's appointment to the Board.

 

For further information, please contact:

 

RWS Holdings plc

Andrew Brode, Chairman

Ian El-Mokadem, Chief Executive Officer

Rod Day, Chief Financial Officer

 

 

 

01753 480200

 

MHP (Financial PR advisor)

Katie Hunt / Simon Hockridge

 

rws@mhpc.com

020 3128 8100

 

Numis (Nomad & Joint Broker)

Stuart Skinner / Kevin Cruickshank / Will Baunton

 

 

 

020 7260 1000

 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff

 

020 3207 7800

 

About RWS:

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our unique combination of technology and cultural expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Our clients include 90 of the world's top 100 brands, the top 20 pharmaceutical companies and 19 of the top 20 patent filers. Our client base spans Europe, Asia Pacific and North and South America. We work in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors, which we serve from 80+ global locations across five continents.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

For further information, please visit: www.rws.com.

 

Candy Davies (aged 48) holds or has held directorships in the five years preceding her appointment at the Company as follows:

Current:

None

Last 5 years:

Reckitt Benckiser Healthcare (CIS) Limited

Reckitt Benckiser USA (2010) LLC

R&C Nominees Limited

Reckitt & Colman Holdings Limited

Reckitt Benckiser USA Finance (No.3) Limited

Reckitt & Sons Limited

Reckitt Benckiser Finance (2005) Limited

Hamol Limited

RB Reigate (UK) Limited

Reckitt Benckiser Holdings (USA) Limited

Reckitt Benckiser USA Finance (No.1) Limited

Reckitt Benckiser Healthcare (Mema) Limited

Reckitt & Colman Pension Trustee Limited

Reckitt Benckiser Luxembourg (No.3) Limited

ERH Propack Limited

Reckitt Benckiser Treasury (2007) Limited

Reckitt Benckiser Finance Company Limited

Reckitt Benckiser Luxembourg (No.1) Limited

Reckitt Benckiser (USA) Limited

Reckitt Benckiser Asia Pacific Limited

R&C Nominees One Limited

RB Holdings (Nottingham) Limited

Reckitt Benckiser Service Bureau Limited

Glasgow Square Limited

Howard Lloyd & Company Limited

R&C Nominees Two Limited

Reckitt Colman Chiswick (OTC) Limited

Reckitt & Colman (UK) Limited

Reckitt Benckiser USA Finance (No.2) Limited

Reckitt Benckiser Luxembourg (No.4) Limited

Reckitt Benckiser Healthcare (Central & Eastern Europe) Limited

Suffolk Finance Company Limited

Lloyds Pharmaceuticals

Crookes Healthcare Limited

Green, Young & Company Limited

Optrex Limited

Nurofen Limited

Reckitt Benckiser Holdings (Overseas) Limited

Helpcentral Limited

Reckitt Benckiser Luxembourg (No.2) Limited

Reckitt Benckiser Investments Limited

Reckitt Benckiser (Grosvenor) Holdings Limited

W. Woodward Limited

SSL (RB) Products Limited

Reckitt Seton Limited

Cupal Limited

Sonet Products Limited

Dakin Brothers Limited

Scholl Consumer Products Limited

Durex Limited

Reckitt & Colman Trustee Services Limited

SSL (SD) International Limited

Scholl (Investments) Limited

Seton Healthcare No.1 Trustee Limited

SSL (C C Services) Limited

British Surgical Industries Limited

New Bridge Street Invoicing Limited

SSL (MG) Products Limited

Rivalmuster

Sonet Group Limited

Open Championship Limited

Earex Products Limited

Brevet Hospital Products (UK) Limited

Ultra Chemical Limited

Sonet Scholl Healthcare Limited

Ultra Laboratories Limited

Sonet Scholl Healthcare International Limited

Seton Healthcare Group No.2 Trustee Limited

Sonet Healthcare Limited

SSL (C C Manufacturing) Limited

Prebbles Limited

LRC Investments Limited

29 St Leonard's Avenue Limited

Reckitt & Colman (Overseas) Limited

Reckitt Benckiser Limited

SSL International Plc

Reckitt Benckiser Treasury Services Plc

Reckitt Benckiser Jersey (No.2) Limited

Sonet Overseas Investments Limited

Reckitt Benckiser Holdings (Luxembourg) Limited

Reckitt Benckiser Jersey (No.3) Limited

Reckitt Benckiser Jersey (No.1) Limited

RB (China Trading) Limited

RB Mexico Investments Limited

RB Asia Holding Limited

Reckitt Benckiser (Rumea) Limited

Reckitt Benckiser (Brands) Limited

Reckitt Benckiser Corporate Services Limited

RB Luxembourg (2016) Limited

MJ UK Holdings Limited

RB Reigate (2019) Limited

RB USA (2019) Limited

Reckitt Benckiser (Cayman Islands) Limited

Reckitt Benckiser Jersey (No.5) Limited

Reckitt & Colman (Jersey) Limited

Reckitt & Colman Capital Finance Limited

SSL Capital Limited

Reckitt Benckiser USA (2013) LLC

Reckitt Benckiser Asia Pacific Limited - Japan Branch

Reckitt Benckiser Holdings (USA) Limited - Luxembourg branch

The French's Food Finance Company Limited - Luxembourg branch

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFIFDAISIIF
Date   Source Headline
1st Oct 20257:00 amRNSTotal Voting Rights
1st Sep 20253:09 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNSHolding(s) in Company
18th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202511:11 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20259:25 amRNSHolding(s) in Company
23rd Jul 20254:29 pmRNSHolding(s) in Company
18th Jul 20251:19 pmRNSHolding(s) in Company - amendment
16th Jul 20254:01 pmRNSHolding(s) in Company
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSChange of Nominated Adviser
26th Jun 202511:00 amRNS-RAcquisition of IP of Papercup
23rd Jun 202510:46 amRNSHolding(s) in Company
18th Jun 202512:30 pmRNSHolding(s) in Company
18th Jun 202510:12 amRNSHolding(s) in Company
17th Jun 202511:29 amRNSFurther re Half Year Report
17th Jun 20257:00 amRNSHalf-year Report
11th Jun 20257:00 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSHolding(s) in Company
6th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
12th May 20259:15 amRNS-RAppointment of Chief Product & Technology Officer
8th May 202511:51 amRNSDirector/PDMR Shareholding
6th May 202510:10 amRNSHolding(s) in Company
2nd May 20259:15 amRNSHolding(s) in Company
1st May 20252:15 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSHolding(s) in Company
25th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Statement
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSChange of Registered Office
3rd Mar 20258:55 amRNSTotal Voting Rights
14th Feb 20253:51 pmRNSHolding(s) in Company
13th Feb 202512:33 pmRNSDirector/PDMR Shareholding
11th Feb 202512:14 pmRNSResult of AGM
11th Feb 20257:00 amRNSAGM Statement
10th Feb 20254:57 pmRNSHolding(s) in Company
3rd Feb 20255:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:58 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20252:06 pmRNSDirector/PDMR Shareholding
28th Jan 20252:04 pmRNSDirector/PDMR Shareholding
28th Jan 20252:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20253:58 pmRNSOption Exercise, Admission and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.